Golden
Vivax Bio

Vivax Bio

Headquartered in New York, NY, Vivax Bio is a biotech company focused on 3D bioprinting.

Headquartered in New York, NY, Vivax Bio is a biotech company focusing on 3D bioprinting and the hardware, materials, technologies, and products related to the industry. Their product pipeline comprises the FABION bioprinter, a new line of bioprinters based on different technologies, including in situ portable bioprinters, and various tissue and organ constructs. Most of Vivax Bio's research and development is based in Moscow, Russia, where their wholly owned subsidiary, 3D Bioprinting Solutions, is located. Vivax Bio’s New York location is mainly focused on sales and marketing.



As of November 2018, the company focused on cultured meat. The company thinks that 3D bioprinting has the potential to reduce the cost of cultured meat. Vivax Bio launched its magnetic bioprinter, OrganAut, on board the ISS, and hope to use this participation in the international space program as a stepping stone towards bringing cultured/printed meat to consumers.



On the ISS Russian cosmonaut Oleg Kononenko used the OrganAut 3D bioprinter to bioprint human cartilage tissue and a rodent thyroid gland while in space. Experiments on the ISS as of 2019 include biofabrication of protein crystals, biofilms and cultured meat constructs. The company plans to implement an in-situ bioprinter that combines a medical robotic arm with classic bioprinting extrusion technologies to allow medical procedures to be performed inside surgery rooms. 



3D Bioprinting Solutions has a core purpose of advancing tissue engineering and performs research in 3D printed organ transplants in mice. The FABION 3D bioprinter can be used to print functional mouse thyroid glands without the need for organic or artificial scaffolds for the cells to be placed onto. FABION 2 is a newer printhead that is able to bioprint with single tissue spheroids in complex structures with a range of hydrogels. The FABION 2 became the OrganAut device. The company is developing 3D bioprinted tissues and organoid models out of human cells for drug discovery and disease modeling purposes. 



Timeline

People

Name
Role
LinkedIn

Yakov Balakhovsky

CEO, CFO



Yusef Khesuani

President, Vivax Bio and CEO, 3D Bioprinting Solutions



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services









References